Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Rat IL-17E, Carrier-Free Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Manufacturer:  R&D Systems™ 8949IL025/CF

Catalog No. 89-49I-L025CF

Add to cart
This item is not returnable. View return policy



The Recombinant Rat IL-17E Protein is derived from HEK293. The Recombinant Rat IL-17E Protein has been validated for the following applications: Bioactivity.


Human embryonic kidney cell, HEK293-derived Val17-Ala169
Observed M.W.: 19-25kDa, reducing conditions, Theoretical M.W.: 18kDa
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -70° C under sterile conditions after reconstitution.
IL17E, IL-17E, IL17Einterleukin-17E, IL25, IL-25, interleukin 17E, interleukin 25, Interleukin-17E, interleukin-25
>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining
Human embryonic kidney cell,HEK293-derived rat IL-17E/IL-25 protein Val17-Ala169
<0.10 EU per 1μg of the protein by the LAL method.
Measured by its ability to induce CXCL1/GRO alpha secretion in HT-29 human colon adenocarcinoma cells. The ED50 for this effect is typically 0.25-1.25ng/mL.
Product Certifications
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit